Stock Earnings
IONS’s latest rating updates from top analysts.
In a filing, Ionis Pharmaceuticals Inc revealed its Director Hayden Michael R acquired Company’s shares for reported $0.48 million on
Menu
In a filing, Ionis Pharmaceuticals Inc revealed its Director Hayden Michael R acquired Company’s shares for reported $0.48 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its